BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zákostelská Z, Málková J, Klimešová K, Rossmann P, Hornová M, Novosádová I, Stehlíková Z, Kostovčík M, Hudcovic T, Štepánková R, Jůzlová K, Hercogová J, Tlaskalová-Hogenová H, Kverka M. Intestinal Microbiota Promotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response. PLoS One 2016;11:e0159539. [PMID: 27434104 DOI: 10.1371/journal.pone.0159539] [Cited by in Crossref: 84] [Cited by in F6Publishing: 89] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Q, Yu J, Zhou H, Wang X, Zhang C, Hu J, Hu Y, Zheng H, Zeng F, Yue C, Gu L, Wang Z, Zhao F, Zhou P, Zhang H, Huang N, Wu W, Zhou Y, Li J. Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism. Signal Transduct Target Ther 2023;8:40. [PMID: 36710269 DOI: 10.1038/s41392-022-01219-0] [Reference Citation Analysis]
2 Gonzalez JR, Celli A, Weckel A, Dhariwala MO, Merana GR, Ojewumi OT, Okoro J, Dwyer LR, Tran VM, Meyer JM, Mauro TM, Scharschmidt TC. FLG Deficiency in Mice Alters the Early-Life CD4(+) T-Cell Response to Skin Commensal Bacteria. J Invest Dermatol 2022:S0022-202X(22)02822-6. [PMID: 36496196 DOI: 10.1016/j.jid.2022.10.019] [Reference Citation Analysis]
3 Lee H, Kim M. Skin Barrier Function and the Microbiome. IJMS 2022;23:13071. [DOI: 10.3390/ijms232113071] [Reference Citation Analysis]
4 Controne I, Scoditti E, Buja A, Pacifico A, Kridin K, Fabbro MD, Garbarino S, Damiani G. Do Sleep Disorders and Western Diet Influence Psoriasis? A Scoping Review. Nutrients 2022;14:4324. [PMID: 36297008 DOI: 10.3390/nu14204324] [Reference Citation Analysis]
5 Su T, Liu F, Kou C, Liu H, Xu S, Zhang D, Wei-xin F, Fang C, Zhang M. Characteristic of decreased bacterial diversity in psoriasis. Arq Bras Med Vet Zootec 2022;74:767-777. [DOI: 10.1590/1678-4162-12583] [Reference Citation Analysis]
6 Pinget GV, Tan JK, Ni D, Taitz J, Daien CI, Mielle J, Moore RJ, Stanley D, Simpson S, King NJC, Macia L. Dysbiosis in imiquimod-induced psoriasis alters gut immunity and exacerbates colitis development. Cell Rep 2022;40:111191. [PMID: 35977500 DOI: 10.1016/j.celrep.2022.111191] [Reference Citation Analysis]
7 Buhaș MC, Gavrilaș LI, Candrea R, Cătinean A, Mocan A, Miere D, Tătaru A. Gut Microbiota in Psoriasis. Nutrients 2022;14:2970. [DOI: 10.3390/nu14142970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Harris-Tryon TA, Grice EA. Microbiota and maintenance of skin barrier function. Science 2022;376:940-5. [PMID: 35617415 DOI: 10.1126/science.abo0693] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
9 Bae SS, Dong TS, Wang J, Lagishetty V, Katzka W, Jacobs JP, Charles-Schoeman C. Altered Gut Microbiome in Patients With Dermatomyositis. ACR Open Rheumatol 2022. [PMID: 35615912 DOI: 10.1002/acr2.11436] [Reference Citation Analysis]
10 Garabatos N, Santamaria P. Gut Microbial Antigenic Mimicry in Autoimmunity. Front Immunol 2022;13:873607. [PMID: 35572569 DOI: 10.3389/fimmu.2022.873607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Thye AY, Bah Y, Law JW, Tan LT, He Y, Wong S, Thurairajasingam S, Chan K, Lee L, Letchumanan V. Gut–Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis. Biomedicines 2022;10:1037. [DOI: 10.3390/biomedicines10051037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wang X, Liu X, Xiao S, Zhang Z, Wu L, Cheng Y, Tan Y, Zhang G, Jiang C. Comparison of gut microbiota compositions and corresponding genetic and metabolic features between guttate and plaque psoriasis by metagenomic sequencing. Microbial Pathogenesis 2022. [DOI: 10.1016/j.micpath.2022.105560] [Reference Citation Analysis]
13 Zhang C, Merana GR, Harris-Tryon T, Scharschmidt TC. Skin immunity: dissecting the complex biology of our body's outer barrier. Mucosal Immunol 2022. [PMID: 35361906 DOI: 10.1038/s41385-022-00505-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Widhiati S, Purnomosari D, Wibawa T, Soebono H. The role of gut microbiome in inflammatory skin disorders: A systematic review. Dermatol Reports 2022;14:9188. [PMID: 35371420 DOI: 10.4081/dr.2022.9188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Monir RL, Schoch JJ. Clinical Relevance of the Microbiome in Pediatric Skin Disease: A Review. Dermatologic Clinics 2022. [DOI: 10.1016/j.det.2021.12.001] [Reference Citation Analysis]
16 Chen P, Tang X. Gut Microbiota as Regulators of Th17/Treg Balance in Patients With Myasthenia Gravis. Front Immunol 2021;12:803101. [PMID: 35003133 DOI: 10.3389/fimmu.2021.803101] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
17 Pereira MS, Redanz S, Kriegel MA. Skin Deep: The Role of the Microbiota in Cutaneous Autoimmunity. J Invest Dermatol 2022:S0022-202X(21)02612-9. [PMID: 35027173 DOI: 10.1016/j.jid.2021.12.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Zeng L, Yu G, Wu Y, Hao W, Chen H. The Effectiveness and Safety of Probiotic Supplements for Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Preclinical Trials. J Immunol Res 2021;2021:7552546. [PMID: 34938815 DOI: 10.1155/2021/7552546] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Gangwar RS, Gudjonsson JE, Ward NL. Mouse Models of Psoriasis: A Comprehensive Review. J Invest Dermatol 2021:S0022-202X(21)01442-1. [PMID: 34953514 DOI: 10.1016/j.jid.2021.06.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
20 Sun C, Chen L, Yang H, Sun H, Xie Z, Zhao B, Jiang X, Qin B, Shen Z. Involvement of Gut Microbiota in the Development of Psoriasis Vulgaris. Front Nutr 2021;8:761978. [PMID: 34881280 DOI: 10.3389/fnut.2021.761978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Chen HL, Zeng YB, Zhang ZY, Kong CY, Zhang SL, Li ZM, Huang JT, Xu YY, Mao YQ, Cai PR, Han B, Wang WQ, Wang LS. Gut and Cutaneous Microbiome Featuring Abundance of Lactobacillus reuteri Protected Against Psoriasis-Like Inflammation in Mice. J Inflamm Res 2021;14:6175-90. [PMID: 34853526 DOI: 10.2147/JIR.S337031] [Reference Citation Analysis]
22 Zhao L, Zhang X, Zhu L, Geng S, Guo K. Effectiveness and safety of Adalimumab in psoriasis and its influence on gut microbiome. Microb Pathog 2021;162:105308. [PMID: 34843923 DOI: 10.1016/j.micpath.2021.105308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Fernández-Gallego N, Sánchez-Madrid F, Cibrian D. Role of AHR Ligands in Skin Homeostasis and Cutaneous Inflammation. Cells 2021;10:3176. [PMID: 34831399 DOI: 10.3390/cells10113176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
24 Suzuki K, Suzuki K, Yabe Y, Iida K, Ishikawa J, Makita S, Kageyama T, Iwamoto T, Tanaka S, Yokota M, Iwata A, Suto A, Nakajima H. NF-κB1 Contributes to Imiquimod-Induced Psoriasis-Like Skin Inflammation by Inducing Vγ4+Vδ4+γδT17 Cells. J Invest Dermatol 2021:S0022-202X(21)02483-0. [PMID: 34774872 DOI: 10.1016/j.jid.2021.11.004] [Reference Citation Analysis]
25 Bokoliya SC, Dorsett Y, Panier H, Zhou Y. Procedures for Fecal Microbiota Transplantation in Murine Microbiome Studies. Front Cell Infect Microbiol 2021;11:711055. [PMID: 34621688 DOI: 10.3389/fcimb.2021.711055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
26 Movahedan A, Barba H, Spedale M, Deng N, Arvans D, Nadeem U, Leone V, Chang EB, Theriault B, Skondra D. Gnotobiotic Operations and Assembly for Development of Germ-Free Animal Model of Laser-Induced Choroidal Neovascularization. Transl Vis Sci Technol 2021;10:14. [PMID: 34388237 DOI: 10.1167/tvst.10.9.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Yan D, Gudjonsson JE, Le S, Maverakis E, Plazyo O, Ritchlin C, Scher JU, Singh R, Ward NL, Bell S, Liao W. New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine. J Invest Dermatol 2021;141:2112-2122.e3. [PMID: 34303522 DOI: 10.1016/j.jid.2021.02.764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Craft J, Edington H, Christman ND, Chaston J, Erickson D, Wilson E. Increased microbial diversity and decreased prevalence of common pathogens in the gut microbiomes of wild turkeys compared to domestic turkeys.. [DOI: 10.1101/2021.07.16.452759] [Reference Citation Analysis]
29 Di T, Zhao J, Wang Y, Han L, Guo X, Han X, Chen Z, Li P, Lu C. Tuhuaiyin alleviates imiquimod-induced psoriasis via inhibiting the properties of IL-17-producing cells and remodels the gut microbiota. Biomed Pharmacother 2021;141:111884. [PMID: 34243099 DOI: 10.1016/j.biopha.2021.111884] [Reference Citation Analysis]
30 Rungjang A, Meephansan J, Bing Thio H. Skin and Gut Microbiota in Psoriasis: A Systematic Review. Human Microbiome 2021. [DOI: 10.5772/intechopen.92686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Gupta M, Weinberg JM, Yamauchi PS, Patil A, Grabbe S, Goldust M. Psoriasis: Embarking a dynamic shift in the skin microbiota. J Cosmet Dermatol 2021. [PMID: 34089221 DOI: 10.1111/jocd.14273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Giulio P. The intestinal microbiota: Towards a multifactorial integrative model. Eubiosis and dysbiosis in morbid physical and psychological conditions. Arch Clin Gastroenterol 2021. [DOI: 10.17352/2455-2283.000094] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
33 Shinno-Hashimoto H, Hashimoto Y, Wei Y, Chang L, Fujita Y, Ishima T, Matsue H, Hashimoto K. Abnormal composition of microbiota in the gut and skin of imiquimod-treated mice. Sci Rep 2021;11:11265. [PMID: 34050205 DOI: 10.1038/s41598-021-90480-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
34 Ogawa C, Inoue R, Yonejima Y, Hisa K, Yamamoto Y, Suzuki T. Supplemental Leuconostoc mesenteroides strain NTM048 attenuates imiquimod-induced psoriasis in mice. J Appl Microbiol 2021. [PMID: 34028144 DOI: 10.1111/jam.15161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Berlinberg A, Kuhn KA. Barrier lymphocytes in spondyloarthritis. Curr Opin Rheumatol 2020;32:343-8. [PMID: 32412993 DOI: 10.1097/BOR.0000000000000716] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
36 Olejniczak-Staruch I, Ciążyńska M, Sobolewska-Sztychny D, Narbutt J, Skibińska M, Lesiak A. Alterations of the Skin and Gut Microbiome in Psoriasis and Psoriatic Arthritis. Int J Mol Sci 2021;22:3998. [PMID: 33924414 DOI: 10.3390/ijms22083998] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
37 Ito Y, Sasaki T, Li Y, Tanoue T, Sugiura Y, Skelly AN, Suda W, Kawashima Y, Okahashi N, Watanabe E, Horikawa H, Shiohama A, Kurokawa R, Kawakami E, Iseki H, Kawasaki H, Iwakura Y, Shiota A, Yu L, Hisatsune J, Koseki H, Sugai M, Arita M, Ohara O, Matsui T, Suematsu M, Hattori M, Atarashi K, Amagai M, Honda K. Staphylococcus cohnii is a potentially biotherapeutic skin commensal alleviating skin inflammation. Cell Rep 2021;35:109052. [PMID: 33910010 DOI: 10.1016/j.celrep.2021.109052] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
38 Xiao S, Zhang G, Jiang C, Liu X, Wang X, Li Y, Cheng M, Lv H, Xian F, Guo X, Tan Y. Deciphering Gut Microbiota Dysbiosis and Corresponding Genetic and Metabolic Dysregulation in Psoriasis Patients Using Metagenomics Sequencing. Front Cell Infect Microbiol 2021;11:605825. [PMID: 33869074 DOI: 10.3389/fcimb.2021.605825] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
39 Zhang X, Shi L, Sun T, Guo K, Geng S. Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients. BMC Microbiol 2021;21:78. [PMID: 33685393 DOI: 10.1186/s12866-021-02125-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
40 Sánchez D, Hoffmanová I, Szczepanková A, Hábová V, Tlaskalová-Hogenová H. Contribution of Infectious Agents to the Development of Celiac Disease. Microorganisms 2021;9:547. [PMID: 33800833 DOI: 10.3390/microorganisms9030547] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
41 Gao Y, Lu J, Bao X, Yi X, Peng C, Chen W, Zhen T, Shi Y, Xing K, Zhu S, Ding Y. Inhibition of phospholipases suppresses progression of psoriasis through modulation of inflammation. Exp Biol Med (Maywood) 2021;246:1253-62. [PMID: 33641447 DOI: 10.1177/1535370221993424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Li XQ, Chen Y, Dai GC, Zhou BB, Yan XN, Tan RX. Abietic acid ameliorates psoriasis-like inflammation and modulates gut microbiota in mice. J Ethnopharmacol 2021;272:113934. [PMID: 33607198 DOI: 10.1016/j.jep.2021.113934] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
43 Shi Z, Wu X, Santos Rocha C, Rolston M, Garcia-Melchor E, Huynh M, Nguyen M, Law T, Haas KN, Yamada D, Millar NL, Wan YY, Dandekar S, Hwang ST. Short-Term Western Diet Intake Promotes IL-23‒Mediated Skin and Joint Inflammation Accompanied by Changes to the Gut Microbiota in Mice. J Invest Dermatol 2021;141:1780-91. [PMID: 33485880 DOI: 10.1016/j.jid.2020.11.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
44 Afonina IS, Van Nuffel E, Beyaert R. Immune responses and therapeutic options in psoriasis. Cell Mol Life Sci 2021;78:2709-27. [PMID: 33386888 DOI: 10.1007/s00018-020-03726-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
45 Dusek O, Fajstova A, Klimova A, Svozilkova P, Hrncir T, Kverka M, Coufal S, Slemin J, Tlaskalova-Hogenova H, Forrester JV, Heissigerova J. Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917. Cells 2020;10:E23. [PMID: 33375578 DOI: 10.3390/cells10010023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
46 Chen L, Li J, Zhu W, Kuang Y, Liu T, Zhang W, Chen X, Peng C. Skin and Gut Microbiome in Psoriasis: Gaining Insight Into the Pathophysiology of It and Finding Novel Therapeutic Strategies. Front Microbiol 2020;11:589726. [PMID: 33384669 DOI: 10.3389/fmicb.2020.589726] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 10.7] [Reference Citation Analysis]
47 Chen YJ, Ho HJ, Wu CY, Juan CK, Wu CY. Infantile infection and antibiotic exposure in association with pediatric psoriasis development: A nationwide nested case-control study. J Am Acad Dermatol 2021;85:626-35. [PMID: 33321158 DOI: 10.1016/j.jaad.2020.12.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
48 Abu Tayeh A, Funabiki M, Shimizu S, Satoh S, Sumin L, Iwakura Y, Kato H, Fujita T. Psoriasis-like skin disorder in transgenic mice expressing a RIG-I Singleton-Merten syndrome variant. Int Immunol 2021;33:211-24. [PMID: 33119735 DOI: 10.1093/intimm/dxaa071] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Drake D. The Gut Microbiome‐Skin Axis. In: Dayan N, editor. Skin Microbiome Handbook. Wiley; 2020. pp. 33-44. [DOI: 10.1002/9781119593058.ch2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Dei-Cas I, Giliberto F, Luce L, Dopazo H, Penas-Steinhardt A. Metagenomic analysis of gut microbiota in non-treated plaque psoriasis patients stratified by disease severity: development of a new Psoriasis-Microbiome Index. Sci Rep 2020;10:12754. [PMID: 32728075 DOI: 10.1038/s41598-020-69537-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
51 Koper M, Woźniacka A, Robak E. The intestinal microbiota in psoriasis. Postepy Hig Med Dosw 2020;74:236-46. [DOI: 10.5604/01.3001.0014.3052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
52 Mann EA, Bae E, Kostyuchek D, Chung HJ, McGee JS. The Gut Microbiome: Human Health and Inflammatory Skin Diseases. Ann Dermatol 2020;32:265-72. [PMID: 33911753 DOI: 10.5021/ad.2020.32.4.265] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
53 Hurabielle C, Link VM, Bouladoux N, Han SJ, Merrill ED, Lightfoot YL, Seto N, Bleck CKE, Smelkinson M, Harrison OJ, Linehan JL, Tamoutounour S, Lionakis MS, Kaplan MJ, Nakajima S, Belkaid Y. Immunity to commensal skin fungi promotes psoriasiform skin inflammation. Proc Natl Acad Sci U S A 2020;117:16465-74. [PMID: 32601220 DOI: 10.1073/pnas.2003022117] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 14.3] [Reference Citation Analysis]
54 Schön MP, Manzke V, Erpenbeck L. Animal models of psoriasis-highlights and drawbacks. J Allergy Clin Immunol 2021;147:439-55. [PMID: 32560971 DOI: 10.1016/j.jaci.2020.04.034] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
55 Sikora M, Stec A, Chrabaszcz M, Knot A, Waskiel-Burnat A, Rakowska A, Olszewska M, Rudnicka L. Gut Microbiome in Psoriasis: An Updated Review. Pathogens 2020;9:E463. [PMID: 32545459 DOI: 10.3390/pathogens9060463] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 9.7] [Reference Citation Analysis]
56 Maruoka N, Watanabe B, Ando D, Miyashita M, Kurihara T, Hokazono H. Effects of a pyroglutamyl pentapeptide isolated from fermented barley extract on atopic dermatitis-like skin lesions in hairless mouse. Biosci Biotechnol Biochem 2020;84:1696-705. [PMID: 32404002 DOI: 10.1080/09168451.2020.1762480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Okada K, Matsushima Y, Mizutani K, Yamanaka K. The Role of Gut Microbiome in Psoriasis: Oral Administration of Staphylococcus aureus and Streptococcus danieliae Exacerbates Skin Inflammation of Imiquimod-Induced Psoriasis-Like Dermatitis. Int J Mol Sci 2020;21:E3303. [PMID: 32392785 DOI: 10.3390/ijms21093303] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
58 Chen HH, Lin CC, Tung YT, Chao YH, Huang WC, Lee PY. Combination Therapy of Acarbose and Cyclosporine a Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice. Molecules 2020;25:E1822. [PMID: 32316255 DOI: 10.3390/molecules25081822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
59 Yeh NL, Hsu CY, Tsai TF, Chiu HY. Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment. Clin Drug Investig 2019;39:1195-203. [PMID: 31549347 DOI: 10.1007/s40261-019-00849-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
60 Manley GC, Lee Y, Zhang Y. Gut microbiota and immunology of the gastrointestinal tract. Clinical and Basic Neurogastroenterology and Motility 2020. [DOI: 10.1016/b978-0-12-813037-7.00004-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Harris-tryon TA, Bel S. Gene/Environment Interaction and Autoimmune Disease. Beyond Our Genes 2020. [DOI: 10.1007/978-3-030-35213-4_8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Coughlin CC, Mccoy WH. Cutaneous Microbiome. Harper's Textbook of Pediatric Dermatology 2019. [DOI: 10.1002/9781119142812.ch3] [Reference Citation Analysis]
63 Cheng H, Guan X, Chen D, Ma W. The Th17/Treg Cell Balance: A Gut Microbiota-Modulated Story. Microorganisms 2019;7:E583. [PMID: 31756956 DOI: 10.3390/microorganisms7120583] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
64 Polkowska‐pruszyńska B, Gerkowicz A, Krasowska D. The gut microbiome alterations in allergic and inflammatory skin diseases – an update. J Eur Acad Dermatol Venereol 2019;34:455-64. [DOI: 10.1111/jdv.15951] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
65 Ellis SR, Nguyen M, Vaughn AR, Notay M, Burney WA, Sandhu S, Sivamani RK. The Skin and Gut Microbiome and Its Role in Common Dermatologic Conditions. Microorganisms 2019;7:E550. [PMID: 31717915 DOI: 10.3390/microorganisms7110550] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 14.3] [Reference Citation Analysis]
66 Fu Y, Lee CH, Chi CC. Association of Psoriasis With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. JAMA Dermatol. 2018;154:1417-1423. [PMID: 30422277 DOI: 10.1001/jamadermatol.2018.3631] [Cited by in Crossref: 105] [Cited by in F6Publishing: 110] [Article Influence: 26.3] [Reference Citation Analysis]
67 Kunz M, Simon JC, Saalbach A. Psoriasis: Obesity and Fatty Acids. Front Immunol 2019;10:1807. [DOI: 10.3389/fimmu.2019.01807] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
68 Shapiro J, Cohen NA, Shalev V, Uzan A, Koren O, Maharshak N. Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls. J Dermatol 2019;46:595-603. [PMID: 31141234 DOI: 10.1111/1346-8138.14933] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 14.5] [Reference Citation Analysis]
69 Stehlikova Z, Kostovcik M, Kostovcikova K, Kverka M, Juzlova K, Rob F, Hercogova J, Bohac P, Pinto Y, Uzan A, Koren O, Tlaskalova-Hogenova H, Jiraskova Zakostelska Z. Dysbiosis of Skin Microbiota in Psoriatic Patients: Co-occurrence of Fungal and Bacterial Communities. Front Microbiol 2019;10:438. [PMID: 30949136 DOI: 10.3389/fmicb.2019.00438] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 12.0] [Reference Citation Analysis]
70 Horváth S, Komlódi R, Perkecz A, Pintér E, Gyulai R, Kemény Á. Methodological refinement of Aldara-induced psoriasiform dermatitis model in mice. Sci Rep 2019;9:3685. [PMID: 30842501 DOI: 10.1038/s41598-019-39903-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
71 Stehlikova Z, Kostovcikova K, Kverka M, Rossmann P, Dvorak J, Novosadova I, Kostovcik M, Coufal S, Srutkova D, Prochazkova P, Hudcovic T, Kozakova H, Stepankova R, Rob F, Juzlova K, Hercogova J, Tlaskalova-Hogenova H, Jiraskova Zakostelska Z. Crucial Role of Microbiota in Experimental Psoriasis Revealed by a Gnotobiotic Mouse Model. Front Microbiol 2019;10:236. [PMID: 30846974 DOI: 10.3389/fmicb.2019.00236] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
72 Visser MJE, Kell DB, Pretorius E. Bacterial Dysbiosis and Translocation in Psoriasis Vulgaris. Front Cell Infect Microbiol 2019;9:7. [DOI: 10.3389/fcimb.2019.00007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 12.3] [Reference Citation Analysis]
73 Kennedy EA, King KY, Baldridge MT. Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria. Front Physiol. 2018;9:1534. [PMID: 30429801 DOI: 10.3389/fphys.2018.01534] [Cited by in Crossref: 230] [Cited by in F6Publishing: 245] [Article Influence: 46.0] [Reference Citation Analysis]
74 Chen YJ, Ho HJ, Tseng CH, Lai ZL, Shieh JJ, Wu CY. Intestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients. Exp Dermatol 2018;27:1336-43. [PMID: 30238519 DOI: 10.1111/exd.13786] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 9.2] [Reference Citation Analysis]
75 Balato A, Cacciapuoti S, Di Caprio R, Marasca C, Masarà A, Raimondo A, Fabbrocini G. Human Microbiome: Composition and Role in Inflammatory Skin Diseases. Arch Immunol Ther Exp (Warsz) 2019;67:1-18. [PMID: 30302512 DOI: 10.1007/s00005-018-0528-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 8.2] [Reference Citation Analysis]
76 Huang L, Gao R, Yu N, Zhu Y, Ding Y, Qin H. Dysbiosis of gut microbiota was closely associated with psoriasis. Sci China Life Sci 2019;62:807-15. [PMID: 30264198 DOI: 10.1007/s11427-018-9376-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
77 Kiyohara H, Sujino T, Teratani T, Miyamoto K, Arai MM, Nomura E, Harada Y, Aoki R, Koda Y, Mikami Y, Mizuno S, Naganuma M, Hisamatsu T, Kanai T. Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells. Cell Mol Gastroenterol Hepatol 2019;7:135-56. [PMID: 30510995 DOI: 10.1016/j.jcmgh.2018.09.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
78 Opazo MC, Ortega-Rocha EM, Coronado-Arrázola I, Bonifaz LC, Boudin H, Neunlist M, Bueno SM, Kalergis AM, Riedel CA. Intestinal Microbiota Influences Non-intestinal Related Autoimmune Diseases. Front Microbiol 2018;9:432. [PMID: 29593681 DOI: 10.3389/fmicb.2018.00432] [Cited by in Crossref: 99] [Cited by in F6Publishing: 103] [Article Influence: 19.8] [Reference Citation Analysis]
79 Lukic J, Chen V, Strahinic I, Begovic J, Lev-Tov H, Davis SC, Tomic-Canic M, Pastar I. Probiotics or pro-healers: the role of beneficial bacteria in tissue repair. Wound Repair Regen 2017;25:912-22. [PMID: 29315980 DOI: 10.1111/wrr.12607] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 12.6] [Reference Citation Analysis]
80 Fiore M, Leone S, Maraolo AE, Berti E, Damiani G. Liver Illness and Psoriatic Patients. Biomed Res Int 2018;2018:3140983. [PMID: 29546055 DOI: 10.1155/2018/3140983] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
81 Castelino M, Eyre S, Barton A. Psoriasis and Psoriatic Arthritis. The Microbiome in Rheumatic Diseases and Infection 2018. [DOI: 10.1007/978-3-319-79026-8_18] [Reference Citation Analysis]
82 Welcome MO. Functional Relationship Between the Gut and Other Tissues/Organs of the Body. Gastrointestinal Physiology 2018. [DOI: 10.1007/978-3-319-91056-7_15] [Reference Citation Analysis]
83 Dimmitt RA, Sellers ZM, Sibley E. Gastrointestinal Tract Development. Avery's Diseases of the Newborn 2018. [DOI: 10.1016/b978-0-323-40139-5.00070-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
84 Vaughn AR, Notay M, Clark AK, Sivamani RK. Skin-gut axis: The relationship between intestinal bacteria and skin health. World J Dermatol 2017; 6(4): 52-58 [DOI: 10.5314/wjd.v6.i4.52] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
85 Luger TA, Loser K. Novel insights into the pathogenesis of psoriasis. Clin Immunol 2018;186:43-5. [PMID: 28736273 DOI: 10.1016/j.clim.2017.07.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
86 Maguire M, Maguire G. The role of microbiota, and probiotics and prebiotics in skin health. Arch Dermatol Res 2017;309:411-21. [PMID: 28631091 DOI: 10.1007/s00403-017-1750-3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 8.2] [Reference Citation Analysis]
87 Yan D, Issa N, Afifi L, Jeon C, Chang HW, Liao W. The Role of the Skin and Gut Microbiome in Psoriatic Disease. Curr Dermatol Rep 2017;6:94-103. [PMID: 28804689 DOI: 10.1007/s13671-017-0178-5] [Cited by in Crossref: 65] [Cited by in F6Publishing: 51] [Article Influence: 10.8] [Reference Citation Analysis]